GIP-GLP-1 dual agonist compounds and methods
Abstract:
The present invention relates to acylated GIP analogs which have dual GIP and GLP-1 activity, and their use in the treatment of metabolic disorders.
Public/Granted literature
Information query
Patent Agency Ranking
0/0